Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Alhambra, California, United States
- Facility name not stated
Bakersfield, California, United States
- Facility name not stated
La Verne, California, United States
- Facility name not stated
Long Beach, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Northridge, California, United States
- Facility name not stated
Redondo Beach, California, United States
- Facility name not stated
Santa Barbara, California, United States
- Facility name not stated
Santa Maria, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Grand Junction, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Facility name not stated
Stamford, Connecticut, United States
- Facility name not stated
Waterbury, Connecticut, United States
- Facility name not stated
Fort Myers, Florida, United States
- Facility name not stated
Hollywood, Florida, United States
- Facility name not stated
Pembroke Pines, Florida, United States
- Facility name not stated
Athens, Georgia, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Lawrenceville, Georgia, United States
- Facility name not stated
Marietta, Georgia, United States
- Facility name not stated
Roswell, Georgia, United States
- Facility name not stated
Harvey, Illinois, United States
- Facility name not stated
Park Ridge, Illinois, United States
- Facility name not stated
South Bend, Indiana, United States
- Facility name not stated
Terre Haute, Indiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
Bethesda, Maryland, United States
- Facility name not stated
Lansing, Michigan, United States
- Facility name not stated
Jackson, Mississippi, United States
- Facility name not stated
Tupelo, Mississippi, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Lincoln, Nebraska, United States
- Facility name not stated
Henderson, Nevada, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Morristown, New Jersey, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Armonk, New York, United States
- Facility name not stated
Great Neck, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2010
- Primary completion
- 30 Apr 2012
- Completion
- 30 Apr 2012
- Last update posted
- 2 Jul 2013
- Registered enrollment
- 468
- Registry id
- NCT01097018
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.